Takeda, Eli Lilly Partner To Sell Evista In Seven Asian Nations
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical and Eli Lilly have formed a partnership in which the Japanese maker is to market and distribute Evista (raloxifene)